126.
[1]. Christopher LJ, et, al. Metabolism and disposition of dasatinib after oral administration to humans. Drug Metab Dispos. 2008 Jul;6():15-64.
[2]. Furlong MT, et, al. A validated LC-MS/MS assay for the simultaneous determination of the anti-leukemic agent dasatinib and two pharmacologically active metabolites in human plasma: application to a clinical pharmacokinetic study. J Pharm Biomed Anal. 2012 Jan 25;58:10-5.
H02-H15-H1-H5
P261-P264-P20-P21-P280-P02+P52-P04+P40-P0-P62+P64-P405-P501
GHS0